DR. MICHAEL O IDOWU, M.D.
Medical Practice at Marshall St, Richmond, VA
License number
Virginia 0101236339
Category
Medical Practice
Type
Anatomic Pathology
Address
Address
1250 E Marshall St, Richmond, VA 23298
Phone
(804) 828-9739
(804) 828-9746 (Fax)
(804) 358-6100
(804) 342-7619 (Fax)
(804) 828-9746 (Fax)
(804) 358-6100
(804) 342-7619 (Fax)
Personal information
See more information about MICHAEL O IDOWU at radaris.comName
Address
Phone
7504 Exmouth Dr, Richmond, VA 23225
Richmond, VA
311 Franklin St, Richmond, VA 23220
1478 Brownleaf Dr, Richmond, VA 23225
7504 Exmouth Dr, Richmond, VA 23225
Professional information
Michael O Idowu, Richmond VA
Specialties:
Anatomic & Clinical Pathology
Address:
VCU Medical Center Pathology
1101 E Marshall St SUITE 4010, Richmond 23298
(804) 828-9746 (Phone)
1101 E Marshall St SUITE 4010, Richmond 23298
(804) 828-9746 (Phone)
Certifications:
Anatomic & Clinical Pathology, 2005
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University Of Ibadan, College Of Medicine
Med College Of Virginia /Vcuhs
Memorial Sloan Kettering Cancer Center
University Of Ibadan, College Of Medicine
Med College Of Virginia /Vcuhs
Memorial Sloan Kettering Cancer Center
Associate Professor, Pathology At Vcu Health System
Location:
Richmond, Virginia Area
Industry:
Hospital & Health Care
Michael O Idowu, Richmond VA
Specialties:
Pathologist
Address:
1250 E Marshall St, Richmond, VA 23298
Education:
Doctor of Medicine*
Board certifications:
American Board of Pathology Certification in Clinical Pathology (Pathology)*
Signatures Associated With Rejection Or Recurrence Of Cancer
US Patent:
2011003, Feb 10, 2011
Filed:
Aug 20, 2010
Appl. No.:
12/859933
Inventors:
Masoud Manjili - Richmond VA, US
Maciej Kmieciak - Richmond VA, US
Harry D. Bear - Richmond VA, US
Catherine I. Dumur - Richmond VA, US
Michael O. Idowu - Richmond VA, US
Maciej Kmieciak - Richmond VA, US
Harry D. Bear - Richmond VA, US
Catherine I. Dumur - Richmond VA, US
Michael O. Idowu - Richmond VA, US
International Classification:
C40B 30/04, C12Q 1/68, C12M 1/34, C40B 40/06, C40B 60/12
US Classification:
506 9, 435 6, 4352872, 506 16, 506 39
Abstract:
Methods and tools for assessing the prognosis for patients following treatment of primary tumors are provided. The methods involve identifying immune-related genetic markers whose differential expression patterns at tumor lesions are indicative of either tumor recurrence or recurrence-free survival. The methods and tools of the invention assist physicians by providing objective decision-making tools for planning patient treatment protocols.